Sanofi unveils unifying corporate brand

Pharma News: Sanofi reveals a new bold corporate brand that supports the modernisation and transformation the company launched in December 2019.

Over the last 50 years, Sanofi has grown into a diverse, global healthcare leader, with a rich heritage of patient-centric scientific discovery. This history includes the first treatments for many rare diseases and the establishment of standards of care in diabetes and cardiovascular disease. Sanofi’s commitment to public health has helped protect hundreds of millions of people from influenza every year for decades and pushed polio to the brink of eradication, while its scientific vision has led to breakthrough innovations in the treatment of inflammatory diseases.

With roots in a variety of diverse companies, Sanofi is today the combination of many cultures, identities, and brands. Its new brand is rooted in this heritage and brings this diverse history together in a single common identity for the first time. This manifestation of the company’s journey highlights an ambitious strategy for the future.

Karen Hood, Country Lead Sanofi Australia and New Zealand, said “After more than 25 years I can honestly say that my experience of Sanofi is one of a company that has always built on its heritage of scientific discovery, commitment to patients, innovation, and care. We were innovators who over time acquired other innovators and grew to support patients and customers across the healthcare sector in our pursuit to improve lives. For me, our purpose and new common corporate identity isn’t a departure from that legacy it draws from it. And it brings us together as one, in a way that truly values our past as much as our future.”

Paul Hudson, CEO of Sanofi, commented “As we approach the half century mark of our company’s existence, we have undertaken the most important transformation and modernisation in our history. In 2019, we launched our Play to Win strategy, which focuses on applying our platform for innovation to produce first- and best-in-class treatments and vaccines. Our new brand is a natural and important next step in this journey and represents the integrated way in which the company will work to achieve our shared ambition to transform the practice of medicine.”

Current business units Sanofi Pasteur and Sanofi Genzyme, focused on vaccines and specialty care respectively, and all other acquired brands, will be united under the singular Sanofi name and brand. These brands have for years symbolised the impact that innovation can have on people’s lives. Thinking, acting, and behaving as a single entity under a new shared purpose and identity will position Sanofi to have greater impact by more strategically applying the resources that exist across the company to drive innovations that matter.

The new logo is a representation of Sanofi’s new purpose and ambition, which is inspired by the simple and motion-oriented codes of the tech industry. The two purple dots embody the scientific journey between a starting point – the curiosity of questioning the status-quo and wondering “what if?” – and a finish line – the eureka moment where innovative solutions are unlocked to impact people’s lives. 

Josep Catllà, Head of Corporate Affairs at Sanofi, added “With our new brand, we have sought to provide our people, our partners, patients and healthcare professionals with a clear and strong understanding of who we are and what we are set to achieve. Sanofi’s attitude is humble, authentic—and a little bit unconventional too. We believe that our new brand and logo carve out a unique space in the healthcare industry that perfectly represents our new purpose to chase the miracles of science to improve people’s lives.”